To better assess the prognostic value of maspin gene expression in ERα-positive breast cancer, we quantified maspin mRNA content in an additional independent well-defined cohort of 105 ERα-positive postmenopausal breast cancer patients treated with primary surgery followed by adjuvant tamoxifen alone. The gene discussed is SERPINB5; the disease is breast carcinoma.